Nivolumab trials for Prostate cancer

All Nivolumab trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Nivolumab for Prostate cancer

• FOG-001 in Locally Advanced or Metastatic Solid Tumors
  NCT05919264 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 33 locations
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
  NCT05176483 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 244 locations
• Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
  NCT03866382 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 581 locations

Common questions

How many trials study Nivolumab for Prostate cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.